Combination Therapy with Chinese Medicine and ACEI/ARB for the Management of Diabetic Nephropathy: The Promise in Research Fragments

摘要

Background: The clinical benefits of the application of renin-angiotensin system (RAS) blockade, i.e., angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), have been well established in patients with diabetic nephropathies (DN). Since the combination therapy with Chinese Medicine (CM) and conventional western medicine (CWM) is considered an effective approach to many conditions, many CM experts have investigated the combination therapy with CM and RAS blockade to look for new approaches to DN.